Literature DB >> 27895041

Infections and the risk of incident giant cell arteritis: a population-based, case-control study.

Rennie L Rhee1, Peter C Grayson2, Peter A Merkel1,3, Gunnar Tomasson4.   

Abstract

OBJECTIVES: Alterations in the immune system and infections are suspected to increase susceptibility to giant cell arteritis (GCA). Recently herpes zoster has been directly implicated in the pathogenesis of GCA. We examined the association between prior infections, in particular herpes zoster, and incident GCA in a population-based cohort.
METHODS: A nested case-control study was performed using an electronic database from the UK. Cases with newly diagnosed GCA were identified using a validated algorithm and compared with age-matched, sex-matched and practice-matched controls. Conditional logistic regression was used to examine the relationship between any infection or herpes zoster infection on the development of GCA after adjusting for potential confounders; results were expressed as incidence rate ratios (IRRs).
RESULTS: There were 4559 cases of GCA and 22 795 controls. Any prior infection and herpes zoster were associated with incident GCA (IRR 1.26 (95% CI 1.16 to 1.36), p<0.01; and 1.17 (95% CI 1.04 to 1.32), p<0.01, respectively). A greater number of infections was associated with a higher risk of developing GCA (IRR for 1, 2-4 and ≥5 infections was 1.28, 1.60 and 2.18, respectively).
CONCLUSIONS: Antecedent infections and, to a lesser extent, herpes zoster infections are modestly associated with incident GCA. These data provide population-level support for the hypothesis that long-standing alterations of the immune system are associated with susceptibility to GCA and suggest that herpes zoster is unlikely to play a major causal role in the pathogenesis of GCA. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Epidemiology; Giant Cell Arteritis; Infections

Mesh:

Substances:

Year:  2016        PMID: 27895041     DOI: 10.1136/annrheumdis-2016-210152

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  A Case of Giant Cell Arteritis With a Normal Erythrocyte Sedimentation Rate (ESR) Post ChAdOx1 nCoV-19 Vaccination.

Authors:  Chenfan Xia; Rachel Edwards; Bita Omidvar
Journal:  Cureus       Date:  2022-05-27

2.  Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.

Authors:  Bryant R England; Ted R Mikuls; Fenglong Xie; Shuo Yang; Lang Chen; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

3.  Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease?

Authors:  Paolo Falsetti; Edoardo Conticini; Caterina Acciai; Caterina Baldi; Marco Bardelli; Stefano Gentileschi; Luca Cantarini; Bruno Frediani
Journal:  Reumatologia       Date:  2020-04-30

4.  Does low risk of infections as a marker of effective immunity predict increased risk of subsequent giant cell arteritis or polymyalgia rheumatica? A Danish population-based case-control study.

Authors:  Clément Brault; Anders H Riis; Anil Mor; Pierre Duhaut; Reimar W Thomsen
Journal:  Clin Epidemiol       Date:  2018-10-16       Impact factor: 4.790

Review 5.  Giant cell arteritis: is the clinical spectrum of the disease changing?

Authors:  Miguel Á González-Gay; Miguel Ortego-Jurado; Liliana Ercole; Norberto Ortego-Centeno
Journal:  BMC Geriatr       Date:  2019-07-29       Impact factor: 3.921

Review 6.  CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?

Authors:  Rosanne D Reitsema; Annemieke M H Boots; Kornelis S M van der Geest; Maria Sandovici; Peter Heeringa; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

7.  Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study.

Authors:  Edsel B Ing; Royce Ing; Xinyang Liu; Angela Zhang; Nurhan Torun; Michael Sey; Christian Pagnoux
Journal:  Clin Ophthalmol       Date:  2018-01-11

8.  Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis.

Authors:  Christien Rondaan; Kornelis S M van der Geest; Elisabeth Eelsing; Annemieke M H Boots; Nicolaas A Bos; Johanna Westra; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2017-10-24       Impact factor: 7.561

9.  Fever of unknown origin following parathyroidectomy prior to onset of typical polymyalgia rheumatica symptoms: a case report.

Authors:  Akinori Kanzaki; Kiyoshi Matsui; Tadahiko Sukenaga; Koushi Mase; Aya Nishioka; Tomoharu Tamori; Seiko Kataoka; Hiroyuki Konya; Shin Mizutani; Akira Takeda; Masato Koseki; Tetsuo Nishiura; Hidenori Koyama; Hajime Sano
Journal:  Int J Gen Med       Date:  2018-07-16

10.  Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis.

Authors:  Ignatius Ryan Adriawan; Faranaz Atschekzei; Oliver Dittrich-Breiholz; Panagiotis Garantziotis; Stefanie Hirsch; Linus Maximillian Risser; Maike Kosanke; Reinhold Ernst Schmidt; Torsten Witte; Georgios Sogkas
Journal:  Ann Rheum Dis       Date:  2021-09-28       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.